DE69433933D1 - Verfahren und vorrichtung zur einkapselung biologisch aktiver substanzen in zellen - Google Patents

Verfahren und vorrichtung zur einkapselung biologisch aktiver substanzen in zellen

Info

Publication number
DE69433933D1
DE69433933D1 DE69433933T DE69433933T DE69433933D1 DE 69433933 D1 DE69433933 D1 DE 69433933D1 DE 69433933 T DE69433933 T DE 69433933T DE 69433933 T DE69433933 T DE 69433933T DE 69433933 D1 DE69433933 D1 DE 69433933D1
Authority
DE
Germany
Prior art keywords
cells
active substances
red blood
blood cells
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69433933T
Other languages
English (en)
Other versions
DE69433933T2 (de
Inventor
Claude Nicolau
Ulrich Bruggemann
Yousef Mouneimne
Eric Conrad Roux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CBR Laboratories Inc
Original Assignee
CBR Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CBR Laboratories Inc filed Critical CBR Laboratories Inc
Publication of DE69433933D1 publication Critical patent/DE69433933D1/de
Application granted granted Critical
Publication of DE69433933T2 publication Critical patent/DE69433933T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3692—Washing or rinsing blood or blood constituents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
    • A61M1/3696—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging with means for adding or withdrawing liquid substances during the centrifugation, e.g. continuous centrifugation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/02—Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/04—Cell isolation or sorting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0429—Red blood cells; Erythrocytes
DE69433933T 1993-03-23 1994-03-23 Verfahren und vorrichtung zur einkapselung biologisch aktiver substanzen in zellen Expired - Lifetime DE69433933T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3546793A 1993-03-23 1993-03-23
US35467 1993-03-23
PCT/US1994/003189 WO1994021117A1 (en) 1993-03-23 1994-03-23 Method and apparatus for encapsulation of biologically-active substances in cells

Publications (2)

Publication Number Publication Date
DE69433933D1 true DE69433933D1 (de) 2004-09-09
DE69433933T2 DE69433933T2 (de) 2005-07-21

Family

ID=21882856

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69433933T Expired - Lifetime DE69433933T2 (de) 1993-03-23 1994-03-23 Verfahren und vorrichtung zur einkapselung biologisch aktiver substanzen in zellen

Country Status (8)

Country Link
US (1) US5612207A (de)
EP (2) EP0690671B1 (de)
JP (1) JPH08511680A (de)
KR (1) KR960700740A (de)
AT (1) ATE272311T1 (de)
AU (1) AU680890B2 (de)
DE (1) DE69433933T2 (de)
WO (1) WO1994021117A1 (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545130A (en) * 1992-04-08 1996-08-13 Genetronics, Inc. Flow through electroporation method
US6074605A (en) * 1995-03-10 2000-06-13 Entremed, Inc. Flow electroporation chamber and method
US6773669B1 (en) * 1995-03-10 2004-08-10 Maxcyte, Inc. Flow electroporation chamber and method
US6090617A (en) * 1996-12-05 2000-07-18 Entremed, Inc. Flow electroporation chamber with electrodes having a crystalline metal nitride coating
US6096726A (en) 1998-03-11 2000-08-01 Surface Solutions Laboratories Incorporated Multicomponent complex for use with substrate
US6219577B1 (en) 1998-04-14 2001-04-17 Global Vascular Concepts, Inc. Iontophoresis, electroporation and combination catheters for local drug delivery to arteries and other body tissues
EP1075546A1 (de) 1998-05-04 2001-02-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren und vorrichtung zur isolierung von nukleinsäuren
US6175420B1 (en) * 1998-05-20 2001-01-16 Zymequest, Inc. Optical sensors for cell processing systems
US6027488A (en) * 1998-06-03 2000-02-22 Genetronics, Inc. Flow-through electroporation system for ex vivo gene therapy
WO2000006244A2 (en) * 1998-07-30 2000-02-10 Hainfeld James F Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy
WO2000049173A2 (de) 1999-02-15 2000-08-24 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren und probenträgersystem zur trennung und anreicherung von stoffen in situ
FR2792207B1 (fr) * 1999-04-15 2001-06-08 Electricite De France Procede de traitement d'un flux aqueux par electropulsation a champ parallele a l'ecoulement, chambre de pulsation et applications
JP2003507430A (ja) * 1999-08-25 2003-02-25 ジーエムピー カンパニーズ，インコーポレーテッド 哺乳動物中で酸素運搬を向上する薬剤
AU7995600A (en) * 1999-10-05 2001-05-10 Theramed, Inc. Compositions and methods for the incorporation of chemical substances into cells
US7197359B1 (en) 1999-10-14 2007-03-27 Pola Chemical Industries Inc. Compositions for electroporation
CA2395492A1 (en) * 1999-12-22 2001-07-05 Diana Wang Method and apparatus for targeting localised electroporation
US20020142995A1 (en) * 2000-08-01 2002-10-03 Nicolau Yves Claude Ammonium salts of hemoglobin allosteric effectors, and uses thereof
WO2002010177A1 (en) * 2000-08-01 2002-02-07 Gmp Companies, Inc. Ammonium salts of inositol hexaphosphate and uses thereof
ATE332367T1 (de) * 2001-02-09 2006-07-15 Bbk Bio Corp Verfahren zur übertragung ausgewählter moleküle
US7029916B2 (en) 2001-02-21 2006-04-18 Maxcyte, Inc. Apparatus and method for flow electroporation of biological samples
FR2828206B1 (fr) * 2001-08-03 2004-09-24 Centre Nat Rech Scient Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
EP1456345B1 (de) 2001-08-22 2016-07-20 Maxcyte, Inc. Vorrichtung und verfahren zur elektroporation biologischer proben
WO2003026599A1 (en) * 2001-09-26 2003-04-03 The Procter & Gamble Company Personal cleansing compositions comprising silicone resin-containing adhesives
CA2479028A1 (en) * 2002-03-25 2003-10-09 Genetronics, Inc. Minimizing metal toxicity during electroporation enhanced delivery of polynucleotides
EP1503768B1 (de) * 2002-04-29 2015-10-28 NormOxys, Inc. Inositolpyrophosphate und deren Anwendung
WO2004031353A2 (en) * 2002-09-30 2004-04-15 Maxcyte, Inc. Apparatus and method for streaming electroporation
JP4753119B2 (ja) * 2003-03-14 2011-08-24 セレクティス ソシエテ アノニム 大量処理の生体外エレクトロポレーション法
DE10339905B4 (de) * 2003-08-29 2009-04-23 Kist-Europe Forschungsgesellschaft Mbh Implantierbarer Mikrozellprozessor zur Krankheitsbehandlung
US7132242B2 (en) * 2003-11-10 2006-11-07 Hewlett-Packard Development Company, L.P. Method and device for targeted delivery of materials to selected single cells
CN101426929B (zh) 2004-05-12 2011-06-08 麦克赛特股份有限公司 与可调流式电穿孔室相关的方法和装置
US20060258626A1 (en) 2004-07-06 2006-11-16 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
US20060106000A1 (en) * 2004-07-06 2006-05-18 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
US7745423B2 (en) 2004-07-06 2010-06-29 NormOxys, Inc Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
US20070135389A1 (en) * 2004-07-06 2007-06-14 Claude Nicolau Tumor eradication by inositol-tripyrophosphate
JP4919957B2 (ja) 2004-08-02 2012-04-18 グラクソ グループ リミテッド 口腔乾燥症用新規組成物
FR2873925B1 (fr) 2004-08-05 2006-10-13 Erytech Pharma Soc Par Actions Procede et dispositif de lyse-rescellement pour l'incorporation de principe actif notamment asparaginase ou inositol hexaphosphate, dans des erythrocytes
CA2589154A1 (en) 2004-11-30 2006-06-08 Maxcyte, Inc. Computerized electroporation
WO2006063301A1 (en) * 2004-12-10 2006-06-15 Maxcyte, Inc. Genetically modified tumor cells as cancer vaccines
US20060205081A1 (en) * 2005-02-18 2006-09-14 Linhong Li Use of methyltransferase inhibitors to enhance transgene expression
EP1877087B1 (de) * 2005-04-15 2013-02-20 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Verfahren und zusammensetzungen zur erzeugung einer verbesserten immunantwort auf ein menschliches papillomavirus-immunogen
FR2884717B1 (fr) * 2005-04-25 2009-07-03 Erytech Pharma Soc Par Actions Erythrocytes renfermant de l'arginine deiminase
WO2007021994A2 (en) 2005-08-12 2007-02-22 Maxcyte, Inc. Electrode shielding for electroporation
US20070059833A1 (en) * 2005-09-07 2007-03-15 Maxcyte, Inc. Use of Nucleases to Improve Viability and Enhance Transgene Expression in Transfected Cells
US7462485B2 (en) * 2005-10-07 2008-12-09 Glaser Lawrence F Modified erythrocytes and uses thereof
CA2631719A1 (en) * 2005-12-07 2007-10-25 Genetronics, Inc. Variable volume electroporation chamber and methods therefore
US20080138876A1 (en) * 2006-12-11 2008-06-12 Bio-Rad Laboratories, Inc. Transfection in electronically driven continuous flow
ES2534579T3 (es) * 2007-02-23 2015-04-24 Lonza Cologne Gmbh Dispositivo y procedimiento para estabilizar el flujo a través de una cámara
EP2152085A4 (de) * 2007-05-01 2012-05-23 Normoxys Inc Erythropetinkomplementierung oder -ersatz
FR2919804B1 (fr) 2007-08-08 2010-08-27 Erytech Pharma Composition et vaccin therapeutique anti-tumoral
WO2009126789A2 (en) 2008-04-09 2009-10-15 Maxcyte, Inc. Engineering and delivery of therapeutic compositions of freshly isolated cells
JP6025707B2 (ja) 2010-04-06 2016-11-16 エクソサイト セラピューティクス ピーティイー リミテッド 癌を治療する方法
IT1399590B1 (it) * 2010-04-26 2013-04-26 Erydel Spa Apparato e kit per incapsulare almeno un composto ad uso terapeutico e/o diagnostico all'interno di eritrociti
ITBO20100256A1 (it) 2010-04-26 2011-10-27 Erydel Spa Metodo per incapsulare almeno un composto ad uso terapeutico e/o diagnostico all'interno di eritrociti
DK2970915T3 (da) 2013-03-15 2019-11-11 Maxcyte Inc Fremgangsmåder og sammensætninger til generering af stabile transficerede celler
FR3005420B1 (fr) 2013-05-07 2015-09-18 Erytech Pharma Procede de stabilisation de suspensions d'erythrocytes encapsulant un principe actif, suspensions obtenues.
US10849858B2 (en) * 2013-05-10 2020-12-01 Erydel S.P.A. Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
CN107980059B (zh) 2015-04-13 2022-11-11 美克斯细胞有限公司 用于修饰基因组dna的方法和组合物
EP3344575B1 (de) 2015-09-04 2020-04-15 SQZ Biotechnologies Company Intrazelluläres einbringen von biomolekülen in zellen mit einer zellwand
US11225638B2 (en) 2016-04-04 2022-01-18 CyteQuest, Inc. System, device and method for electroporation of cells
WO2018015936A2 (en) 2016-07-21 2018-01-25 Maxcyte, Inc. Methods and compositions for modifying genomic dna
CN114127280A (zh) 2019-05-16 2022-03-01 赛特奎斯公司 用于电穿孔的装置、方法和系统
IT202100023375A1 (it) * 2021-09-09 2023-03-09 Yang Shunfa Dispositivo per la produzione di vescicole bioingegnerizzate dedicate e metodo correlato
CA3233241A1 (en) 2021-09-24 2023-03-30 Maxcyte, Inc. A method of enhanced viral transduction using electroporation
WO2023158755A1 (en) 2022-02-16 2023-08-24 Maxcyte, Inc. A method of cell electroporation

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2955076A (en) * 1955-10-05 1960-10-04 Gen Electric Co Ltd Artificial mutation of micro-organisms by electrical shock
US4370983A (en) * 1971-01-20 1983-02-01 Lichtenstein Eric Stefan Computer-control medical care system
GB1481480A (en) * 1974-02-02 1977-07-27 Kernforschungsanlage Juelich Process and apparatus for increasing the permeability of the membrane of cells of organisms
US4075076A (en) * 1974-06-24 1978-02-21 Kurt Xylander Water treatment apparatus
US4192869A (en) * 1977-09-06 1980-03-11 Studiengesellschaft Kohle Mbh. Controlled improvement of the O2 release by intact erythrocytes with lipid vesicles
DE2740053A1 (de) * 1977-09-06 1979-05-03 Klaus Prof Dr Med Gersonde Verwendung von allosterischen effektoren mit hilfe von lipidvesikeln ueber eine irreversible inkorporierung zwecks verbesserter o tief 2 -entladung des haemoglobins in erythrozyten
US4849355A (en) * 1985-01-08 1989-07-18 Wong Tai Kin Method of transferring genes into cells
FR2529463B1 (fr) * 1982-07-05 1986-01-10 Centre Nat Rech Scient Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus
US4476004A (en) * 1983-04-08 1984-10-09 D.E.P. Systems, Inc. Apparatus for electrofusion of biological particles
DE3317415A1 (de) * 1983-05-13 1984-11-15 Kernforschungsanlage Jülich GmbH, 5170 Jülich Kammer zur behandlung von zellen im elektrischen feld
US4478824A (en) * 1983-08-08 1984-10-23 Franco Robert S Method for altering red blood cell function and survival
EP0137504B1 (de) * 1983-10-13 1991-01-16 Rikagaku Kenkyusho Verfahren und Apparat zum Einpflanzen eines Fremdstoffes in lebende Zelle
US4622302A (en) * 1984-08-09 1986-11-11 American National Red Cross Process for inducing membrane fusion under an electric field
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5100792A (en) * 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
DE3522610A1 (de) * 1985-06-12 1986-12-18 Kernforschungsanlage Jülich GmbH, 5170 Jülich Kammer fuer die behandlung von zellen im elektrischen feld
KR890003947B1 (ko) * 1985-12-11 1989-10-13 가부시기가이샤 시마즈세이사구쇼 세포융합장치
JPS62151174A (ja) * 1985-12-24 1987-07-06 Akira Mizuno 高電圧パルスによる細胞破壊装置
US4695547A (en) * 1986-04-02 1987-09-22 Jeffrey L. Hilliard Probe for electrofusion, electroporation, or like procedure
US4882281A (en) * 1986-04-02 1989-11-21 Jeffrey L. Hilliard Probe for electrofusion, electroporation, or like procedure
US4784737A (en) * 1986-04-18 1988-11-15 The United States Department Of Energy Electromicroinjection of particles into living cells
US4906576A (en) * 1986-05-09 1990-03-06 Electropore, Inc. High speed, high power apparatus for vesicle prealignment, poration, loading and fusion in uniform electric fields and method therefor
US4946793A (en) * 1986-05-09 1990-08-07 Electropore, Inc. Impedance matching for instrumentation which electrically alters vesicle membranes
US4849089A (en) * 1986-05-09 1989-07-18 Electropore, Inc. Disposable electromanipulation chamber
US4923814A (en) * 1986-05-09 1990-05-08 Electropore, Inc. High speed, high power apparatus for vesicle prealignment, poration, loading and fusion in uniform electric fields and method therefor
WO1988004322A1 (en) * 1986-12-07 1988-06-16 Biscar Jean P Artificial gravity cellular molecular injection
US4800163A (en) * 1986-12-15 1989-01-24 Ntl. Inst. of Agrobiological Resources Flow chamber and electro-manipulator incorporating same
US5098843A (en) * 1987-06-04 1992-03-24 Calvin Noel M Apparatus for the high efficiency transformation of living cells
US5128257A (en) * 1987-08-31 1992-07-07 Baer Bradford W Electroporation apparatus and process
GB8721015D0 (en) * 1987-09-07 1987-10-14 Amersham Int Plc Modifying living cells
US4970154A (en) * 1987-10-09 1990-11-13 Baylor College Of Medicine Method for inserting foreign genes into cells using pulsed radiofrequency
US4822470A (en) * 1987-10-09 1989-04-18 Baylor College Of Medicine Method of and apparatus for cell poration and cell fusion using radiofrequency electrical pulses
US4931276A (en) * 1987-10-30 1990-06-05 Franco Robert S Method for introducing desired agents into red blood cells
US4910140A (en) * 1988-04-18 1990-03-20 Bio-Rad Laboratories, Inc. Electroporation of prokaryotic cells
US4956288A (en) * 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5043261A (en) * 1989-04-10 1991-08-27 Cryopharm Corporation Lyophilized and reconstituted red blood cell and hemosome compositions
US4874690A (en) * 1988-08-26 1989-10-17 Cryopharm Corporation Lyophilization of red blood cells
CA1327174C (en) * 1988-10-05 1994-02-22 Youssef Mouneimne Electro-insertion of proteins into animal cell membranes
DE3925680A1 (de) * 1989-08-03 1991-02-07 Kruess Gmbh Wissenschaftliche Verfahren zur herstellung vitaler wirkstoff-beladener humanerythrozyten
US5124259A (en) * 1989-08-23 1992-06-23 Mitsui Toatsu Chemicals, Inc. Method for electroporation
US5135667A (en) * 1990-06-14 1992-08-04 Baxter International Inc. Method and apparatus for administration of anticoagulant to red cell suspension output of a blood separator
US5139684A (en) * 1990-08-06 1992-08-18 Steven Kaali Electrically conductive methods and systems for treatment of blood and other body fluids and/or synthetic fluids with electric forces
US5137817A (en) * 1990-10-05 1992-08-11 Amoco Corporation Apparatus and method for electroporation
US5501662A (en) * 1992-05-22 1996-03-26 Genetronics, Inc. Implantable electroporation method and apparatus for drug and gene delivery
US5424209A (en) * 1993-03-19 1995-06-13 Kearney; George P. Automated cell culture and testing system

Also Published As

Publication number Publication date
EP0690671A4 (de) 1999-04-21
JPH08511680A (ja) 1996-12-10
WO1994021117A1 (en) 1994-09-29
AU6415094A (en) 1994-10-11
AU680890B2 (en) 1997-08-14
ATE272311T1 (de) 2004-08-15
EP1466968A2 (de) 2004-10-13
KR960700740A (ko) 1996-02-24
EP1466968A3 (de) 2006-10-04
EP0690671B1 (de) 2004-08-04
EP0690671A1 (de) 1996-01-10
US5612207A (en) 1997-03-18
DE69433933T2 (de) 2005-07-21

Similar Documents

Publication Publication Date Title
DE69433933D1 (de) Verfahren und vorrichtung zur einkapselung biologisch aktiver substanzen in zellen
CA2214800A1 (en) Flow electroporation chamber and method
DE69430990D1 (de) Zusammensetzung und methode zur anreicherung von weissen blutzellen aus menschlichem vollblut
EP0861894A4 (de) Polypeptid, das die differenzierung unterdrueckt
DE69636398D1 (de) Blutbehandlungssystem und Verfahren zur Gewinnung von mononuklearen Zellen
DE69103631D1 (de) Verbessertes verfahren und apparat, um biologische substanzen in lebenden zellen einzuführen.
DE69001453D1 (de) Vorrichtung zur trennung von mononuklearen zellen aus blut und verfahren zu ihrer herstellung und verwendung.
DE3686361D1 (de) Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magen-darmstoerungen, die von campylobacter polyridis verursacht sind.
PH25590A (en) Active specific immune suppression
AU6804987A (en) Method for treating plasma and products thereof
ATE317847T1 (de) Verfahren und vorrichtung zur nukleinsäurereinigung
DE68914412D1 (de) Methode, System und Apparat zur Züchtung von Zellen.
ATE530253T1 (de) Zusammensetzung, kit und verfahren zur zelltrennung
DE68909997D1 (de) Vorrichtung zur Kultur von tierischen Zellen, Kulturmethode und Mittel zum Nachweis der Kultur.
CA2159005A1 (en) Method and apparatus for encapsulation of biologically-active substances in cells
DE539610T1 (de) Verfahren und Zusammensetzung zur Bestimmung der Immunologischen Aktivität von aktiven Substanzen enthaltende Lösungen.
DE69029446T2 (de) Vorrichtung und Verfahren zur Minimierung der Effekte, des in einem Elektrolyten gelösten Sauerstoffgehaltes, bei Analysatoren für niedrige Sauerstoffkonzentrationen
DE3674213D1 (de) Verfahren zur herstellung von keimabgetoeteten oder in ihrer virulenz abgeschwaechten substanzen sowie deren verwendung.
Carozzi et al. Bone marrow erythroid precursor Ca++ regulates the response to human recombinant erythropoietin (rHuEPO) in hemodialysis patients
DE69027441D1 (en) Ribozymenhemmer
ATE317905T1 (de) Arzneimittel enthaltend wenigstens einen teil des ul84-proteins des cytomegalovirus, verwendung von polypeptiden entsprechend der aminosäuresequenz des ul84-proteins und verfahren zur einführung von ul84 in zielzellen
Carozzi et al. Bone Marrow Erythroid Precursor Cytoplasmic Ca2+ and 1, 25-Dihydroxyvitamin D3 Regulate the Response to Human Recombinant Erythropoietin in Uremia: In Vitro and In Vivo Studies
DE69620358T2 (de) Apparat um biologische Substanzen oder biologisch-aktive Substanzen in lebende Zellen einzuführen
GEU2000600Y (en) Method for Determination of Microelements Content in Biological Materials
DE3685693T2 (de) L-di- oder tripeptide die eine in menschlischer und tierlischer medizin verwendbare biologische wirkung besitzen, verfahren zu ihrer herstellung und sie enthaltende arzneimitteln.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition